Type 1 diabetes (T1D) is characterized by immune-mediated depletion of β-cells resulting in lifelong dependence on exogenous insulin [1]. The treatment of T1D and its complications impose a considerable burden on patients, health care providers and the society. This evidence concerns the gene INS and type 1 diabetes mellitus.